GNFT Genfit Corp Revenue Growth QoQ

Corporate company logo of genfit.com (GNFT)

Reducing portfolio risks through partnerships with industry behemoths promises stable royalties, as evidenced by quarter-over-quarter revenue growth, where the metric stands at -42.20. Genfit S.A. (GNFT) aims to capture the rare liver pathology niche through expansion; however, geopolitical tensions and logistical complexities are hindering international trials and drug exports.

GNFT (Genfit Corp) Revenue Dynamics QoQ history from 07/04/2022 to 12/06/2025

genfit.com (GNFT) - metric breakdowns and financial figures

- stock price and consensus target price:
- market capitalization data:
- cash and cash flow metrics:
General company analysis:GNFT - Genfit S.A.
Flagship merchandise of Genfit S.A.

Genfit S.A. (GNFT) maintains a stable position driven by a consistent stream of licensing payments from liver disease treatments. This indicator measures quarterly revenue growth rates, discounting recent corporate data into a single trend. Investors utilize this balance to assess the effectiveness of long-term partnerships and business liquidity. The final quarterly trading revenue dynamics visualize the growth phases of cash flows.